Getty Images

Q and A with the experts: AstraZeneca and viral vector vaccines

Posted on

The AstraZeneca vaccine has recently been approved in Canada and is evaluated to be about 62 per cent effective in preventing the COVID-19 virus.

Kelly Grindrod, a pharmacist and professor, breaks down how this vaccine and others like it work.

https://uwaterloo.ca/news/media/q-and-experts-astrazeneca-and-viral-vector-vaccines

Read More Impact Stories

Posted on

B.C. researchers identify gene that fuels aggressive childhood cancers

For patients with neuroblastoma, one of the most common solid tumours in children, disease outcomes can vary widely. Some children [...]
Read more
Posted on

Researchers develop first COVID-19 rapid test for wastewater

McMaster researchers have developed the first COVID rapid test for community wastewater, which will make early warning surveillance of infectious [...]
Read more
Posted on

World’s most comprehensive study on COVID-19 mental health

Study shows limited impact of pandemic on mental health, underlining strength of human resilience. COVID-19 has taken a relatively limited [...]
Read more
View All Impact Stories